FindTrial
Sign In

Examination of the medication effect using duloxetine in the patients with burning mouth syndrome and glossodynia

Examination of the medication effect using duloxetine in the patients with burning mouth syndrome and glossodynia - Examination of the medication effect using duloxetine in the patients with burning mouth syndrome and glossodynia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014354
Enrollment
30
Registered
2014-06-25
Start date
2014-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

burning mouth syndrome glossodynia

Interventions

Duloxetine

Sponsors

Depertment of Dental Anesthesiology, Division of Clinical Mediccal Sience, Programs for Applide Biomedicine, Graduate School of Biomedical Scinencice, Hiroshima University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: burning mouth syndrome patients glossodynia patients

Exclusion criteria

Exclusion criteria: patients with grave disease

Design outcomes

Primary

MeasureTime frame
duloxetine six weeks from medication maintenance daily activity of patients psychology test—

Countries

Japan

Contacts

Public ContactMitsuru Doi

Hiroshima University Dental Anesthesiology

doi326@hiroshima-u.ac.jp028-257-5733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026